moatshark My

All holdings

Zoetis

ZTS

Source: the SEC Form 13F filings of the managers we follow, latest for Q3 2026. How we use them

Managers holding
6
In their latest 13F (Q3 2026)
See who
Value held
$381m
Combined value at quarter end
Last quarter
4 bought
4 sold or trimmed
Fund portfolios
2
Funds holding it
See which
Price at Q3 ’26 end
$69.83
-2.8% in the quarter

Prices here are quarter-end prices implied by the 13F filings. Today’s price on Yahoo Finance

Share price change by quarter

-16.6%Q4 ’24
+1.1%Q1 ’25
-5.3%Q2 ’25
-6.2%Q3 ’25
-14.0%Q4 ’25
-6.0%Q1 ’26
-39.2%Q2 ’26
-2.8%Q3 ’26
Q4 ’24: -16.6%; Q1 ’25: +1.1%; Q2 ’25: -5.3%; Q3 ’25: -6.2%; Q4 ’25: -14.0%; Q1 ’26: -6.0%; Q2 ’26: -39.2%; Q3 ’26: -2.8%

Change in the quarter-end price implied by managers’ 13F filings, adjusted for stock splits. Excludes dividends.

Managers holding it, by quarter

6Q4 ’23
7Q1 ’24
7Q2 ’24
7Q3 ’24
7Q4 ’24
7Q1 ’25
9Q2 ’25
8Q3 ’25
4Q4 ’25
5Q1 ’26
6Q2 ’26
1Q3 ’26
Q4 ’23: 6; Q1 ’24: 7; Q2 ’24: 7; Q3 ’24: 7; Q4 ’24: 7; Q1 ’25: 7; Q2 ’25: 9; Q3 ’25: 8; Q4 ’25: 4; Q1 ’26: 5; Q2 ’26: 6; Q3 ’26: 1

Counts the managers on this site whose 13F for that quarter includes Zoetis.

Who holds it

Each manager’s latest 13F, sorted by how much of their portfolio it is. Changes are against their previous quarter.

Managers holding Zoetis
Tweedy, Browne3.0%$40.0m$40.0mNew1 qtr
Ruane, Cunniff & Goldfarb (Sequoia)2.6%$169m$169mTrimmed -3.0%2 qtrs
Smead Capital Management2.4%$110m$110mAdded +28%2 qtrs
Mairs & Power0.3%$33.6m$33.6mAdded +54%14 qtrs
Polen Capital Management0.2%$23.0m$23.0mTrimmed -92%35 qtrs
Markel Group0.0%$4.8m$4.8mNew1 qtr

Download the holders: CSV · JSON · Markdown

About the company

Sector
Health care · Pharmaceutical Preparations
Financial year ends
31 December
Shares outstanding
413m at 31 Jul 2026
SEC filings
Annual reports and other filings on EDGAR

Revenue and profit

$4.6bn2013
$4.8bn2015
$5.3bn2017
$6.3bn2019
$7.8bn2021
$8.5bn2023
$9.5bn2025
2013: $4.6bn; 2014: $4.8bn; 2015: $4.8bn; 2016: $4.9bn; 2017: $5.3bn; 2018: $5.8bn; 2019: $6.3bn; 2020: $6.7bn; 2021: $7.8bn; 2022: $8.1bn; 2023: $8.5bn; 2024: $9.3bn; 2025: $9.5bn
Zoetis revenue and net income by year
YearRevenueNet income
2025$9.5bn$2.7bn
2024$9.3bn$2.5bn
2023$8.5bn$2.3bn
2022$8.1bn$2.1bn
2021$7.8bn$2.0bn
2020$6.7bn$1.6bn
2019$6.3bn$1.5bn
2018$5.8bn$1.4bn
2017$5.3bn$864m
2016$4.9bn$821m
2015$4.8bn$339m
2014$4.8bn$583m
2013$4.6bn$504m

From the company’s XBRL financial statements filed with the SEC, for each financial year. Gaps mean the company didn’t report that figure in a standard form.

Sold out last quarter

In fund portfolios

US-registered funds run by these managers that hold Zoetis, from their latest N-PORT filings.

Funds holding Zoetis
Sequoia FundRuane, Cunniff & Goldfarb (Sequoia)1.8%$65.6m30 Jun 2026
Mairs & Power Growth FundMairs & Power0.5%$25.0m30 Jun 2026